Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$46.82 - $76.2 $13,156 - $21,412
281 Added 4.68%
6,289 $305,000
Q3 2022

Oct 24, 2022

SELL
$70.55 - $111.58 $71,184 - $112,584
-1,009 Reduced 14.38%
6,008 $422,000
Q2 2022

Aug 01, 2022

SELL
$50.24 - $80.48 $602 - $965
-12 Reduced 0.17%
7,017 $524,000
Q1 2022

Apr 22, 2022

SELL
$57.98 - $93.5 $927 - $1,496
-16 Reduced 0.23%
7,029 $435,000
Q4 2021

Jan 31, 2022

BUY
$88.02 - $127.79 $45,770 - $66,450
520 Added 7.97%
7,045 $515,000
Q3 2021

Oct 19, 2021

BUY
$122.75 - $162.68 $260,107 - $344,718
2,119 Added 48.09%
6,525 $746,000
Q2 2021

Jul 21, 2021

SELL
$105.76 - $154.96 $422,405 - $618,910
-3,994 Reduced 47.55%
4,406 $595,000
Q2 2020

Jul 13, 2020

SELL
$29.15 - $61.54 $134,090 - $283,084
-4,600 Reduced 35.38%
8,400 $487,000
Q1 2020

Apr 17, 2020

BUY
$25.01 - $42.4 $25,010 - $42,400
1,000 Added 8.33%
13,000 $468,000
Q3 2019

Oct 15, 2019

BUY
$25.78 - $34.8 $309,360 - $417,599
12,000 New
12,000 $295,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.